Vanguard Fiduciary Trust
RNXT icon

Vanguard Fiduciary Trust’s RenovoRx RNXT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Buy
240,330
+82,428
+52% +$74.9K ﹤0.01% 3523
2026
Q1 		$159K Buy
+157,902
New +$153K ﹤0.01% 3579

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Vanguard Fiduciary Trust's RNXT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its RenovoRx (RNXT) stake by 52% in Q2 2026, buying an estimated $74.9K and bringing the position to 240,330 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #3523.

Vanguard Fiduciary Trust first reported a position in RNXT in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Vanguard Fiduciary Trust held 240,330 shares of RenovoRx worth $236K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 82,428 RenovoRx shares in Q2 2026, an estimated $74.9K.
  • RenovoRx made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3523 holding.
  • Vanguard Fiduciary Trust first reported a position in RenovoRx in Q1 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.